Agilis Medical raises $10M in first capital round under Reg D 506(b)
Agilis Medical, a Delaware corporation incorporated in 2026 and based in Cardiff, CA, is raising $10M under Regulation D 506(b) exemption. The company has sold $4M to one investor so far with a $1K minimum.
Note: Issuer incorporated in 2026 (same year as filing); no placement agent listed despite $10M raise and one investor already closed.
How this compares
- Among 1,636 fund launches filed from CA in the same window it is larger than 40%; the CA median is $19M.
- No earlier fund launch by this sponsor appears on EDGAR.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
People on the filing
| Michael Collins | Executive Officer, Director |
| Benjamin Arnold | Executive Officer, Director |
| Renu Parker | Director |
| Brian Bowman | Executive Officer |
[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers
Signed by Michael Collins, Chief Executive Officer.
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans.